Severe prolonged liver abnormality with jaundice during treatment for granulomatosis with polyangiitis with rituximab and avacopan

Rheumatology (Oxford). 2024 Mar 1;63(3):e101-e103. doi: 10.1093/rheumatology/kead509.

Authors

Kanako Kojima¹, Shoichi Fukui¹, Mai Tanigawa¹, Remi Sumiyoshi¹, Tomohiro Koga¹, Akane Shimakura², Shinji Okano³, Atsushi Kawakami¹

Affiliations

¹ Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
² Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
³ Department of Pathology, Nagasaki University Hospital, Nagasaki, Japan.

PMID: 37740250
DOI: 10.1093/rheumatology/kead509

No abstract available

MeSH terms

Aniline Compounds*
Granulomatosis with Polyangiitis* / complications
Granulomatosis with Polyangiitis* / drug therapy
Humans
Jaundice* / drug therapy
Jaundice* / etiology
Liver
Nipecotic Acids*
Rituximab / therapeutic use

Substances

Rituximab
avacopan
Aniline Compounds
Nipecotic Acids